Other risk factors attributable to diabetes predisposition in Asian populations include a possible genetic susceptibility as well as increases in 1) overall and abdominal obesity, 2) abdominal and visceral adiposity for a given BMI, 3) westernization of diet and lifestyle/urbanization and food supply, 4) over-nutrition, 5) sedentary behavior, 6) cigarette smoking, 7) pancreatic beta cell dysfunction, 8) low birth weight.
Beyond a considerable prevalence, the global economic burden of diabetes is also astounding. In 2015, the US led the world in diabetes related health care related expenditures at 320 billion USD (320 Billion ID) followed by China at 51 billion USD (90 billion ID) [2] . Since 1980, there has been fourfold increase in the number of Asians immigrating to the USA, the majority of which emigrated from China. Currently, the most recent Census data (2010) shows the Asian population grew over 40%, faster than any other race group, over the last decade with almost six percent of the US population now identifying as Asian either solely or in combination with one or more other races [7] . With health care insurance and related costs continuing to rise, it is possible that more individuals may seek more cost effective options to manage their disease. An easily accessible option in the US with cultural significance to a minority population experiencing the most rapid growth is Tradition Chinese Medicine (TCM).
Screening and Diagnosis
A number of risk factors for T2DM have been identified and are used to guide screening efforts in traditional modern medicine (TMM). They include but are not limited to obesity, a sedentary lifestyle, cigarette smoking, a family history of T2DM, prior gestational diabetes, evidence of abnormal glucose metabolism, or being of Asian, Hispanic, or African-American descent. Recommendations for screening exist to identify those at an increased risk of developing diabetes (i.e., prediabetes), as well as those with overt disease. Fortunately, the same tests are used for both screening and diagnosis. The routine screening of adults should begin at 45 years of age, regardless their body weight. As well, any overweight (i.e., BMI ≥25 kg/m 2 or ≥23 kg/m 2 in Asian Americans) adult regardless of age should also be screened. Screening methods involve either the measurement a fasting plasma glucose (FPG), glycosylated hemoglobin (HbA1C), or else a two-hour 75g oral glucose tolerance test (OGTT),). Those with a FPG ≥126 mg/dL, an A1C ≥6.5%, or a plasma glucose of ≥200 mg/dL at two hours during a 75g OGTT meet diagnostic criteria for diabetes, while those with values between 100-125 mg/dL, 140-199 mg/dL, and 5.7-6.4% respectively have impaired glucose tolerance, also referred to as prediabetic [9] . One other method of establishing a diagnosis of diabetes is based on the finding of a random plasma glucose ≥200mg/dL in an individual presenting with the classical symptoms of hyperglycemia [9] . Refer to Table 1 for a summary of diagnostic criteria.
Medical Management of Type II Diabetes Mellitus
Generally speaking, management consists of strategies to reduce hyperglycemia in order to prevent overt disease in those with impaired glucose tolerance, and complications in those with evidence of disease [10] . Effective glycemic control slows disease progression and significantly reduces the risk of longterm microvascular, macrovascular, and neuropathic complications (e.g., retinopathy, nephropathy, neuropathy, peripheral vascular, and coronary artery disease) [11, 12] . As such, at the time diagnosis it is necessary to establish a current estimation of micro and macrovascular disease state or baseline on which future comparisons to gauge the efficacy of treatments can be made. Assessments of an individual's cardiovascular risk factors, (i.e., smoking status, lipid profile, blood pressure), baseline renal function, diabetic foot examination, ophthalmological examination should be completed.
Subsequent management of T2DM in TMM necessitates individually tailored, multifactorial interventions involving a combination of approaches to self-management including educational, supportive, behavioral, nutritional, lifestyle, and pharmaceutical components. Standards of medical care in diabetes are published on an annual basis that contain recommendations for glycemic targets upon which estimates of treatment efficacy can be made [13] . Though not telling of hypoglycemic events or glycemic variability in general, HbA1C does allow for estimation of the average blood glucose concentrations over the past several months and is predictive of diabetic related complications [14, 15] . The target HbA1C indicative of glycemic control and a lower risk of diabetes related microvascular complications in adults in <7%. Additionally, blood glucose self-monitoring is also useful as a means of assessing glycemic control however the timing, frequency, and specific goals of monitoring needs vary between individuals as well as selected treatments.
Initial Strategies
In TMM, the mainstay of preventative measures in those with prediabetes as well as the initial treatment in those with T2DM is a focus on knowledge provision and intensive lifestyle modification with specific goals of weight loss as appropriate, medical nutritional therapy, and 150 minutes of moderately intensive physical activity per week. Intensive lifestyle modification is the initial management strategy used in modern medicine to reduce the prevalence of and initially manage T2DM [16] [17] [18] . Benefits of these types of interventions have been reported in group-based lifestyle interventions in both the residents of China as well as Chinese-speaking immigrants with prediabetes in the USA [16, 19] . The China Da Qing Diabetes Prevention Study found that the effects of a lifestyle intervention over a six-year span can prevent or delay diabetes for up to 14 years post-intervention. As well, those who participated in the intervention spent 3.6 fewer years with diabetes than those who did not [16] . A randomized controlled trial by Yeh et al. (2016) examined the feasibility and acceptability of a community based, intensive lifestyle modification program in a sample of Chinese-speaking immigrants with prediabetes in New York City. At 12 months post-intervention, intervention participants had lost significantly more weight and lower HbA1C, BMI, body fat percentage, and waist circumference [19] .
Pharmaceutical Strategies Used to Achieve Glycemic Control
As depicted in Figure 1 , when intensive lifestyle modification fails to result in adequate glycemic control, antihyperglycemic pharmaceutical interventions are added to the management regime until effect control attained [13] .
Typically, monotherapy is initiated with Metformin. Additional oral
INNOVATIONS in pharmacy
3 hypoglycemic agents are subsequently added as needed when hyperglycemia persists after a three-month trial of a particular drug combination (i.e., 2-drug and 3-drug combinations). Should blood glucose levels remain refractory to a three-month trial of a 3-drug oral antihyperglycemic therapy, injectable antihyperglycemic therapies are used to achieve adequate control.
Medical Management of Type II Diabetes Mellitus Comorbidities
At the time of diagnosis, it essential to obtain baseline assessments for a number of comorbid conditions common in diabetic populations. These conditions typically involve micro and macrovascular predicaments that are often asymptomatic yet advanced at presentation and thus must be managed appropriately.
Atherosclerotic Cardiovascular Disease Cardiovascular Disease Risk Factors
Cardiovascular disease risk factors should be evaluated annually in T2DM. Careful risk factor management strategies such as smoking cessation, low dose aspirin therapy, as well as blood pressure and lipid regulation reduces the likelihood of cardiovascular events.
Hypertension
Blood pressure should be measured at every clinic visit and hypertension managed with a treatment goal of 130-139/70-89mmHg. Angiotensin converting enzyme inhibitors (ACE-I) or angiotensin receptor blockers (ARB) are the drug of choice because as they have been shown to slow the progression of renal disease in hypertensive patients with moderately increased albuminuria (formerly called microalbuminuria) [20] . Substitutions with an alternative class of antihypertensive medication should be when there is ACE-I or ARB intolerance, though it is likely that multiple drugs may be needed to adequately control blood pressure.
Lipid Management
Lipid management is also a key component of T2DM management (see Tables 2 and 3 ). The ADA suggests intensive lifestyle modifications to improve a patient's lipid profile such as optimization of glycemic control; weight loss if indicated; reducing intake of saturated fat, trans fat, and cholesterol; increase intake of omega-3 fatty acids, viscous fiber, and plant stanols or sterols; and increasing physical activity [13] . Statin therapies are the mainstay medical management and recommended for most individuals with diabetes who are forty years of age or older. Additional cardiovascular benefits occur with the addition of ezetimibine to moderately intensive statin therapy, recent acute coronary syndrome, LDL ≥50 mg/dL, or for those intolerant to high intensity statin therapy. Men with triglyceride levels ≥204 mg/dL and a HDL ≤34 mg/dL may benefit from the addition of fenofibrate to statin therapy, but otherwise the combination of fibrates with statin are not recommended. Neither is the combination of statins with niacin as due to an increased risk of cerebrovascular events.
The mechanisms of actions, overall effects of, as well as factors pertinent to patient safety such as precautions, drug interactions, and adverse effects of antihyperglycemic and T2DM comorbid disease management pharmacotherapies are summarized in Table 2 . Throughout history and across the globe, many countries developed their own methods of medical practices which were eventually acknowledged as their own practice of traditional medicine. TCM has been used to treat the ailments of the peoples of Asia since ancient times and in fact was the only form of medical practice available in China until TMM was introduced by missionaries in the early nineteenth century. TCM employs a number of approaches to achieve a healthy body equilibrium founded on "syndrome" also known as "zheng" or "pattern" differentiation [21] . Zheng differentiation provides the conceptual basis on which TCM is built. Zheng differentiation ultimately uses a combination of "symptoms, syndrome, and disease" to treat several chronic non-communicable diseases [22, 23] .
TCM practitioners use four examinations to assess the zheng of a patient [24] . The first examination focuses on the patient's physique, skin complexion, and tongue condition. The second involves listening to the patient's voice to assess respiratory problems such a cough, phlegm as well as evaluating body odors suggestive of ill health. Next, the practitioner will ask the patient how he or she feels overall in terms of their body temperature, perspiration, bowel movements, and thirst etc. Finally, palpations of pulses are used to indicate overall health. The cumulative findings of such examinations suggests a pattern of zheng that establishes a diagnosis and in turn treatment options to resolve underlying problems. Treatment options commonly used in TCM include, but are not limited to the following therapies: herbal medicines, acupuncture, heated cup therapy (cupping), massage therapy (tuina), movement and breathing exercises (qigong), and burnt mogwort therapy (moxibustion).
Xiaoke
TCM has been used to treat DM for more than 2000 years [23, 25] . Initially, practitioners created a word to distinguish a cluster of typical symptoms when diabetes was first observed in ancient China "Xiaoke" [26] . Traditional Xiaoke disease was based on a syndrome or zheng pattern of "three excess and one loss" of the classical presentation of T1DM, excessive thirst, excessive urination, excessive food consumption, and weight loss. The underlying pathological process was believed to be an initial deficiency in yin leading to dryness body heat at times
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4 accompanied with phlegm retention and blood stasis. A prolonged yin deficiency was thought to impair yang leading to qi insufficiency and ultimately leading to a dual deficiency of qi and yin as well as yin and yang. With these beliefs, TCM tenets involve a nourishment of yin with bitter flavors or cold property to enhance qi while clearing of heat from the body promoting fluid production [27] [28] [29] .
Recently with the escalation of T2DM, there is evidence that the zheng of "three excess and one loss" remains only somewhat applicable to T2DM as half of T2DM patients are asymptomatic initially while 80% of those with symptoms present atypically [30] . It is thought that the excesses and loss syndrome typifies more advanced disease as practitioners are now often diagnosing T2DM prior to the appearance of "three excess and one loss" through physical examination and other biometric indicators especially in suspect individuals with obesity and/or central adiposity [30, 31] .
Investigators have recently acknowledged that early and middle stage disease is better represented with a spleen-warm syndrome referred to as "Pi Dan" a direct result of inactivity and an abundance of food consumption. Pi Dan is thought to be caused by an overstimulation of the gastrointestinal tract through too much food consumption leading to excesses in splenic, stomach, liver, gall bladder, and intestinal heats. Similar in TCM pathogenesis evidence of effective management through yin nourishment using herbal preparations with bitter flavor or cold property characteristics [31] .
While the philosophy and occupations of TMM and TCM are unalike leading to different methodologies in the diagnosis and treatment of T2DM, there are a few similarities such as the application of nutrition and exercise as treatment modalities. As in TMM, lifestyle interventions in Chinese individuals involving diet and exercise can prevent or delay the progression of prediabetes to T2DM [16] . Without lifestyle intervention, within 20 years approximately 90% of those with prediabetes progress to T2DM and 50% experience at least one cardiovascular event.
Xiaoke Review of Literature
TCM uses approximately eight hundred different plants and herbs as natural medicines to prevent and treat Xiaokezheng [29] . TCM providers will either give patients a single herb extract, or more often than not a complex formulation of multiple extracts and compounds with the idea of targeting multiple physiological mechanisms within the body to treat T2DM. Unlike TMM where antihyperglycemic medicines typically employ one mechanism of action to lower PBG concentrations, TCM practitioners and researchers proposed that TCM formulations and even single herb preparations often employ a number of mechanisms of action concurrently to do the same [27, 31] . For instance, a review by Wang et al. (2013) proposed that Xiaoke TCM herbal plant extracts used at least one of seven different mechanisms of action many of which act at the same site or on the same physiological pathway as some of the TMM outlined in Figure 1 [27] . As depicted in Figure 2 , itemized the mechanisms of actions were as follows: 1) decreased carbohydrate absorption, 2) improved insulin sensitivity, 3) increased peripheral glucose uptake, 4) stimulate insulin secretion, 5) potentiate endogenous incretins, 6) antioxidant effects decreasing cellular apoptosis, and 7) increased glycogenesis or inhibition of hepatic glycogenolysis [27] .
Consequently, the aforementioned multiple concurrent mechanisms of actions compounded by inherent difficulties in the quantification of chemical compositions and concentrations of each herb added to a complex formulation that has somewhat hindered the widespread use of TCM as a complementary and alternative medicine (CAM) in TMM. Along these lines, there have also been difficulty determining the therapeutic efficacies of various TCMs due to practitioner variations in preparation techniques and applied doses given to patients based on their evaluations of Xiaoke syndrome differentiation. One final contemplation that could quite possibly be hindering implementations of TCMs into TMM lies specifically within a considerable priority in the provision of healthcare in the western world, patient safety and quality assurance. At present, little is known about the possibility of interactions between or adverse effects of simultaneous combinations of TCM formulations with and commonplace TMMs.
Xiaoke Formulations
In 2007, the China Association of Chinese Medicine published the first set of guidelines adopted by TCM primary care physicians in China concerning the prevention and treatment of DM using TCM. Herbal medicines with bitter flavor and cold property have evidence of effective treatment applications. A synopsis of the most common TCM herbal preparations/concoctions used to treat T2DM is presented below. When provided, proposed mechanisms of actions, overall effects of, as well as factors pertinent to patient safety such as precautions, herb/drug interactions, and adverse effects will be included in the review.
Tianqi
Tianqi is a novel Chinese herbal medicine used to treat T2DM in China [32] [33] [34] 
Xiaoke Common Single Ingredients
The previous section reviewed the four most common concoctions used in TCM to treat Xiaoke. Though much of the TCM research has focused on preparations involving multiple ingredients, there is some evidence of single ingredient considerations. Of the four most common TCM preparations identified in the section above, there were several single ingredient commonalities. Specifically, rhizoma coptidis was found in all four formulations and scutellariae was found in three. What follows are in depth reviews of the literature for these two herbs.
Rhizoma Coptidis (Huang Lian)
The primary active ingredient in rhizoma coptidis is berberine [49] . Berberine is a natural plant alkaloid isolated from the Chinese her coptis chiesnensis (huanglain). Table 5 catalogs claims found within the literature relating to the proposed mechanisms of action, precautions, and adverse effects of five other herbs found in the most common TCM herbal preparations identified in section 3.1.1.
Future Directions
The popularity of TCM use has escalated and herbal preparations are now widely available and used throughout USA, Europe, and Australia. In 2010, the US was the biggest importer of TCM articles from China having spent over 7.5 billion dollars on product. According to the CDC, approximately 38% of US adults use some form of Complementary and Alternative Medicine (CAM) with the most utilized therapy being non-vitamin, non-mineral natural products [62] . In the US, TCM herbal preparations or supplements are considered a form of CAM or even at times a nutritional supplement, but are for the most part unregulated by the Food and Drug Administration (FDA). Such ambiguity and paucity in the regulation of TCMs evokes ruminations of the hazards and ill effects of ingesting unknown and unregulated substances [63] .
Beyond this obvious avenue of thought, there is also a lack of quality research to establish the possible clinical efficacies and safety profiles of TCMs.
Clinical trials comparing the effectiveness of TMMs to TCMs in diabetes management are thus justified and warranted. Should these trials of comparative effectiveness find certain TCMs to be inferior or even superior to the TMMs detailed in current T2DM clinical practice guidelines, support for the credibility of TCMs would be attained and may even facilitate the approval of Xiaoke herbal medicines by the FDA.
At present, some research scholars divulge differing opinions about the manner in which TCMs should be implemented in clinical trials of efficacy and even the use of TCM in the modern era in general. Some scholars are certain that TCMs should be quantified, certified and regulated using the rigorous processes that led to the approvals of TMMs for use in the treatment of T2DM in the US, while others trust TCMs should be adopted consistent with the underlying philosophy and methods of practice in TCM as described beforehand. In other words, what is otherwise understood as lack of regulation or vagueness in the doses and compositions of TCM prescriptions and therapies by some parties has actually initiated the announcements of a number of future research foci. For instance, the World Health Organization recognizes a need to identify underlying mechanism of actions in TCM ingredients and has subsequently endorsed an international agreement to support the safe and effective use of TCM within established health care systems of its member states [64] . In time, this will result in TCM preparations becoming as formally defined as TMM medicines (i.e., quantification, clinical efficacy, dosing, pharmacokinetics, pharmacodynamics, adverse effects, precautions etc.) prior to their use in its member states. Such formal definitions of TCMs may generate a wider acceptance of TCM in medical practices in western civilizations. Conversely, the Chinese government and its research community are continuing efforts to regulate traditional herbal medicines just as they evolved from their underlying philosophical system and subsequently implemented in medical practices to treat diabetes for thousands of years. China's FDA promulgated a 2015 edition of the Chinese Pharmacopoeia that promotes the utilization, production, and supervision of Chinese drugs with intent to ensure drug safety and effectiveness for its public [65] .
Irrespective of the approach used to implement TCMs in clinical trials of efficacy, we are of the opinion that the most imperative outcome is effective management of T2DM. Therefore, in addition to ultimately supporting those medicines with established clinical efficacy, we advocate for international research collaborations and overall global capacity building. In doing so, it is entirely possible that in the future, a combination T2DM management strategy from both Chinese and western medical practices may be most effective. In fact, a number of Chinese researchers have already proposed theories describing how TCM and TMM can be implemented together to manage diabetes and its sequelae across the disease spectrum [27, 30, 66] . Much more troublesome than the different operational approaches to TCM employed in clinical trials is the limited knowledge of the potential implications of the concurrent use of TCM and TMM in those who require multiple TMMs to effectively manage a chronic non-communicable disease such as diabetes. Encouraged by concerns of patient safety and the provision of quality healthcare in the US, we suggest that research efforts begin with initial and continued careful evaluations of those who concurrently use TMM, TCM, and other nutritional supplements with particular attention paid to those with T2DM using five or more TMM medications. Programs associated with patient safety such as Patient Safety Organizations (PSO) are uniquely poised to easily complete these types of evaluations and detect any safety related concerns with concurrent uses of TMM and TCM. With pragmatic approaches to document the comparable efficacies of TCMs as well as the prevalence, incidence, and evaluations of the effects of concurrent uses of TMM and TCM use in T2DM identified, we can now contemplate other matters. Earlier we alluded to a possible attractiveness of TCM use in T2DM due to its affordability especially when compared to the increasing costs of TMM, health care insurance, and other health care related costs. We also mentioned the cultural significance of TCM to individuals of Asian descent who are predisposed to T2DM. The spectacular increase in the number of Asian immigrants to the US in the past few decades highlights an important research opportunity in a targeted population. New York City has one of the highest Asian American populations within the US. Previous research has documented the feasibility of data collection in this population within this context. For example, the New York City Health and Nutrition Examination Survey found that almost half of the NYC Asian Americans had prediabetes or diabetes at a lower relative body weight than other population groups [67] . Thus, research about T2DM in Asian American populations in NYC is feasible. Given their access to a variety of culturally acceptable means of blood glucose control, documentation of their TCM use is an admirable opportunity.
It is well known that upon arrival to the US, immigrants are often healthier that those born in the US with lower body mass indexes, higher fruit and vegetable consumptions, and higher levels of certain physical activities [68] [69] [70] [71] [72] [73] [74] [75] . An explanation for these health advantages in first generation immigrants is their maintenance of the cultural beliefs stemming from their country of origin. Another beneficial outcome of research relating to the use of TCM in Asian American populations is documentation of second, third, fourth etc. generation immigrants that have likely become 'westernized'. In other words, subsequent generations of immigrants to the US are likely exposed to the cultural beliefs of their family's original countries of origin however; their belief systems may have been 'Americanized'. Support for this theory comes from evidence of associations of the duration of time spent in the US with overweight and obesity. For example, both Chinese and Filipino immigrants living in NYC for longer durations had higher overweight and obesity risks [76, 77] .
The concept of 'Americanization' allows for the speculation of a further value to research documenting TCM use in America. Race and ethnicity are known as risk factors for T2DM. In addition to some Asian Americans, other minorities also have a higher risk of T2DM than Caucasians such as African Americans, Hispanics and Latinos, American Indians, and Pacific Islanders. Nevertheless it remains unknown to what, if any, extent these minorities use TCMs or other economical dietary supplements with hopes of controlling their prediabetes or diabetes [78] . According to National Health and Nutrition Examination Survey data, over half (52%) of those surveyed reported the use of a dietary supplements in the preceding 30 days [79] . With such a large percentage of Americans reporting the use of dietary supplements and the Centers for Disease Control and Prevention actively working to reverse the epidemic of diabetes in the US, further understanding is warranted.
The principal objective of the current article was to initiate our understanding of TCM by identifying and summarizing existing literature on the most common TCM Xiaoke preparations and disease management strategies from a TMM perspective. TCM researchers and practitioners have made similar efforts to disseminate knowledge concerning their applications of herbal treatments in diabetes so that "the Western people know more about anti-diabetic TCM" [31] . The current article also discussed fundamental differences between the two approaches to medicine in terms of their underlying philosophies, theories, and methods of practice as these differences are often cited as reasons as to why their concurrent practice is problematic. It is our hope that continued discussions such as this will facilitate global partnerships with the same research agendas. Ensuring the safety and efficacy of TCM requires a great deal of research that could be completed in a timely manner through international collaboration. Therefore, it is important for researchers across the globe to first understand each other in order to work together effectively toward a common goal while ensuring patient safety. Figure 1 . The order in the chart was determined by historical availability and the route of administration, with injectables to the right; it is nor meant to denote any specific preference. Potential sequences of antihyperglycemic therapy for patient with type 2 diabetes mellitus are displayed, with the usual transition moving vertically from top to bottom (although horizontal movement within therapy stages is also possible, depending on the circumstances 
